AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9363714
Drug: Follicle stimulating
RxNorm normalized name: follicle stimulating hormone
DrugBank: Follitropin (DB00066)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Follicle stimulating hormone (FSH) therapy
Trial: 1389519
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) 600 mg/m2 plus leucovorin (LV) 500 mg/m2
Trial: 1389519
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) 600 mg/m2 alone
Trial: 26671307
Drug: Subtherapeutic CPAP
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subtherapeutic CPAP (withdrawal of treatment) for 2 weeks
Trial: 22304968
Drug: Complementary and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complementary and Alternative Medicine (CAM) treatments
Trial: 16275967
Drug: Oral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral therapy with magnesium oxide, Lactobacillus acidophilus, and simethicone
Trial: 16275967
Drug: Intravenous hydration,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous hydration, nasogastric-tube decompression and nothing by mouth (control)
Trial: 7630075
Drug: Enteral catheter
RxNorm normalized name: lipase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral catheter feeding using Inpitan, ovolact, and hypernutril administered via the nasal passage into the proximal segment of the jejunum starting 5 to 7 days after the operation.
Trial: 7630075
Drug: Parenteral feeding
RxNorm normalized name: SET,FEEDING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral feeding (Control group).
Trial: 2294793
Drug: Cimetidine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (200 mg every 6 hours)
Trial: 28717512
Drug: Dialectical Behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialectical Behavior Therapy for PTSD (DBT-PTSD)
Trial: 29188854
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nutraceuticals based on Bacopa monnieri, L‐theanine, Crocus sativus, copper, folate and vitamins of B and D group
Trial: 18774567
Drug: 400 microg
RxNorm normalized name: Fentanyl 400 microgram buccal film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 microg sublingual misoprostol
Trial: 14633525
Drug: Ringer's acetate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's acetate solution (25 mL/kg, mean 1565 mL) infused over 15, 30, 45, and 80 min
Trial: 10708287
Drug: Abacavir monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir monotherapy (100, 300 or 600 mg twice daily)
Trial: 10708287
Drug: Abacavir/lamivudine/zidovudine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir/lamivudine/zidovudine combination therapy
Trial: 8415473
Drug: Tianeptine (T)
RxNorm normalized name: tianeptine
DrugBank: Tianeptine (DB09289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tianeptine (T) 37.5 mg/day
Trial: 8415473
Drug: Maprotiline (M)
DrugBank: Maprotiline (DB00934)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maprotiline (M) 75 mg/day
Trial: 8415473
Drug: Tianeptine (T)
RxNorm normalized name: tianeptine
DrugBank: Tianeptine (DB09289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tianeptine (T) with Hormone Replacement Therapy (HRT)
Trial: 3533086
Drug: Suprofen syrup
RxNorm normalized name: Suprofen
DrugBank: Suprofen (DB00870)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suprofen syrup 200 mg
Trial: 3533086
Drug: Metamizole syrup
RxNorm normalized name: Metamizole
DrugBank: Metamizole (DB04817)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metamizole syrup 500 mg
Trial: 17172616
Drug: Pramipexole treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole treatment
Trial: 19637794
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of meropenem (1.0 g/day over 24 hours)
Trial: 19637794
Drug: Intermittent infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent infusion of meropenem (0.5 g infused morning and evening)
Trial: 12466771
Drug: Manipulative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manipulative treatment of the structures of the shoulder girdle in addition to standard treatment by the general practitioner
Trial: 12466771
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment by the general practitioner
Trial: 26251920
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g fish oil/day (540 mg EPA + 360 mg DHA)
Trial: 19659504
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil 20 mg + Amlodipine 5 mg
Trial: 19659504
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil 20 mg alone
Trial: 19659504
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil 20 mg + Atenolol 50 mg
Trial: 11314888
Drug: Toothpaste slurry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toothpaste slurry (3 g/10 ml water)
Trial: 8202902
Drug: Theophylline (sustained
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (sustained release preparation, orally, adjusted to achieve blood level above 55.5 mumol/l)
Trial: 31464354
Drug: Swallowing speed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Swallowing speed for water (measured at 90 mL)
Trial: 31464354
Drug: Swallowing speed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Swallowing speed <10 mL/s
Trial: 29161684
Drug: Higher intensity
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Higher intensity CRRT (effluent flow 40 mL/kg/h)
Trial: 29161684
Drug: Lower intensity
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower intensity CRRT (effluent flow 25 mL/kg/h)
Trial: 17696230
Drug: HD-03/ES (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HD-03/ES (two capsules twice daily for six months)
Trial: 17239273
Drug: Parenteral estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral estrogen
Trial: 17239273
Drug: Conventional androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional androgen deprivation therapy (ADT)
Trial: 15133780
Drug: New therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New therapy during open-label follow-up phase
Trial: 8872767
Drug: Daily consecutive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily consecutive administration of 9 million units (MU) IFN‐alpha for 2 weeks and thereafter 3 MU intermittently 3 times weekly for 22 weeks (Group A)
Trial: 8872767
Drug: Exclusively intermittent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exclusively intermittent administration; 9 MU IFN‐alpha twice weekly or 6 MU IFN‐alpha thrice weekly for 24 weeks (Group B)
Trial: 3382764
Drug: Prednisolone at
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone at a dose of 5 mg twice a day
Trial: 6239689
Drug: Tamoxifen at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen at a dose of 10 mg twice a day
Trial: 25920500
Drug: Budesonide MMX
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide MMX 9 mg as monotherapy
Trial: 25920500
Drug: Budesonide MMX
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide MMX 9 mg as add-on therapy to 5-ASAs
Trial: 25920500
Drug: Budesonide MMX
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide MMX 9 mg monotherapy in CORE I study extension
Trial: 16752263
Drug: 25 microg
RxNorm normalized name: Digoxin 125 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 microg vaginal tablets of misoprostol
Trial: 16752263
Drug: One-eighth of
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-eighth of a 200-microg oral tablet administered intravaginally
Trial: 15701186
Drug: Three monthly
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three monthly subcutaneous injections of 3.6 mg of goserelin
Trial: 15701186
Drug: Single subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single subcutaneous injection of 10.8 mg of goserelin
Trial: 30306229
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg E2-valerate
Trial: 27496252
Drug: Conventional implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional implants (control group, Ø3.3‐3.7mm, L11‐13mm)
Trial: 27496252
Drug: Mini implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mini implants (study group, Ø1.8‐2.4mm, L13‐15mm)
Trial: 25287156
Drug: Proteinuria present
RxNorm normalized name: Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine
DrugBank: Covid-19 Coronavirus Artificial Antigen Presenting Cell Vaccine (DB15813)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proteinuria present (P/C ratio >23 mg/mmol)
Trial: 25287156
Drug: No proteinuria
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No proteinuria (P/C ratio ≤23 mg/mmol)
Trial: 20063135
Drug: Remifentanil 1.32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil 1.32 microg.kg(‐1) co-administered with propofol 2.5 mg.kg(‐1)
Trial: 20063135
Drug: Remifentanil doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil doses of 0.25, 0.5, 1, or 2 microg.kg(‐1)
Trial: 8624292
Drug: Fixed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed treatment (FT) - 4 full MOPP/ABVD courses
Trial: 8624292
Drug: Individual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual treatment (IT) - treatment up to complete remission (CR)
Trial: 31794566
Drug: Art Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Art Therapy (AT)
Trial: 22868657
Drug: raloxifene hydrochloride
RxNorm normalized name: Raloxifene Hydrochloride
DrugBank: Raloxifene (DB00481)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: raloxifene hydrochloride 60 mg/day
Trial: 22868657
Drug: alfacalcidol 1
RxNorm normalized name: alfacalcidol 1 MCG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alfacalcidol 1 μg/day
Trial: 21575502
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine group (large dose compound Sophora flavescens Ait injection, 20 ml/d, 21 days as a cycle)
Trial: 30076946
Drug: Chemotherapy group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy group
Trial: 21575502
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese medicine group
Trial: 10845879
Drug: Droloxifene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droloxifene (60 mg/d)
Trial: 10845879
Drug: Conjugated estrogen
RxNorm normalized name: Conjugated estrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogen (0.625 mg/d)
Trial: 8764787
Drug: Topical anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical anesthesia (0.75% bupivacaine)
Trial: 19137863
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Topical and Retrobulbar)
Trial: 19043151
Drug: Cognitive Analytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Analytic Therapy (CAT)
Trial: 31849170
Drug: Increased daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased daily walking steps for 6 months
Trial: 28395364
Drug: Oral Paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Paracetamol
Trial: 28395364
Drug: Oral Ibuprofen
RxNorm normalized name: ibuprofen Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Ibuprofen
Trial: 18837771
Drug: TJ-48 (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TJ-48 (7.5 g/d, n=22)
Trial: 17076223
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of bisoprolol and enalapril with trimetasidine (70 mg/day from postmyocardial day 7-10 for 6 months)
Trial: 17076223
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of bisoprolol and enalapril without trimetasidine
Trial: 12411847
Drug: Hypodermoclysis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypodermoclysis with 1000 ml 5% dextrose in water infusion plus 140 mEq/L sodium chloride at 42 ml/hour per day
Trial: 12411847
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care with subcutaneous drugs (haloperidol 2.5 mg every 4 hours and/or metoclopramide 10 mg every 4 hours)
Trial: 6385678
Drug: Hydralazine (149
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine (149 +/- 11 mg daily)
Trial: 28678111
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Batroxobin and Tranexamic Acid (Group BT)
Trial: 25576896
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of injectable powder of pure HSYA (IPPH) at doses of 25, 50, and 75 mg
Trial: 25576896
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of 50 mg IPPH, once daily for 7 consecutive days
Trial: 25576896
Drug: Single and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single and multiple dosing of IPPH
Trial: 10461765
Drug: Terazosin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (1 mg)
Trial: 10895397
Drug: tolcapone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolcapone (100 or 200 mg three times daily)
Trial: 8644624
Drug: Chronic oral
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic oral sotalol
Trial: 6378158
Drug: Phenylephrine hydrochloride
RxNorm normalized name: Phenylephrine Hydrochloride
DrugBank: Phenylephrine (DB00388)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylephrine hydrochloride nose drops or nasal spray
Trial: 24050737
Drug: Glimepiride (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glimepiride (2 mg)
Trial: 21859060
Drug: 0.9% sodium
RxNorm normalized name: LMD with 0.9% Sodium Chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% sodium chloride (saline solution)
Trial: 16955184
Drug: Topical morphine
RxNorm normalized name: morphine Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical morphine gel 0.3%
Trial: 11509270
Drug: Conventional analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional analgesia (parenteral opiates)
Trial: 9928856
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of aprotinin (Group B)
Trial: 7988583
Drug: Anaesthetic solution
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anaesthetic solution injected into the perivascular axillary sheath (12 ml of a mixture of equal parts of 0.5% bupivacaine with 1:200,000 adrenaline and 2% lignocaine)
Trial: 1102232
Drug: Butorphanol tartrate
RxNorm normalized name: Butorphanol Tartrate
DrugBank: Butorphanol (DB00611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Butorphanol tartrate (1 mg)
Trial: 1102232
Drug: Butorphanol tartrate
RxNorm normalized name: Butorphanol Tartrate
DrugBank: Butorphanol (DB00611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Butorphanol tartrate (2 mg)
Trial: 1102232
Drug: Butorphanol tartrate
RxNorm normalized name: Butorphanol Tartrate
DrugBank: Butorphanol (DB00611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Butorphanol tartrate (4 mg)
Trial: 30630555
Drug: group rumination-focused
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: group rumination-focused cognitive-behavioural therapy (RFCBT)
Trial: 21443271
Drug: Crotalidae polyvalent
RxNorm normalized name: Antivenin,crotalidae polyvalent
DrugBank: Viper antivenom (DB14114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crotalidae polyvalent immune Fab (IV administration)
Trial: 15521841
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (13-15 mg/kg/day) + Mycophenolate mofetil (1000 mg b.d.)
Trial: 15521841
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (13-15 mg/kg/day)
Trial: 9254071
Drug: Mixed meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mixed meal containing 63 g fat and 150,000 IU vitamin A
Trial: 1483485
Drug: Sinemet CR
RxNorm normalized name: Sinemet CR
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sinemet CR (200 mg levodopa/50 mg carbidopa)
Trial: 8485018
Drug: Madopar CR
RxNorm normalized name: Madopar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Madopar CR (100 mg levodopa/25 mg benserazide)
Trial: 2442994
Drug: Ethmozine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethmozine (600 to 900 mg/day in 3 equally divided doses)
Trial: 2442994
Drug: Ethmozine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethmozine plus Propranolol (40 mg, 3 times daily)
Trial: 2442994
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg, 3 times daily)
Trial: 2442994
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Ethmozine plus Propranolol)
Trial: 2442994
Drug: Ethmozine or
RxNorm normalized name: Ethmozine Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethmozine or combination therapy
Trial: 29543126
Drug: Suspension-training movement
RxNorm normalized name: fluorexon stain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension-training movement program (6 weeks, two 1-hour sessions per week)
Trial: 19337387
Drug: Salsalate (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salsalate (4.5 g/d)
Trial: 19337387
Drug: Salsalate (3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salsalate (3.0 g/d)
Trial: 19337387
Drug: Salsalate (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salsalate (maximum tolerable dose, no tinnitus)
Trial: 8970352
Drug: Low-dose dopamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dopamine (LDD) 3 micrograms/kg/min
Trial: 3361170
Drug: Metoclopramide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide (1 mg/kg, 4 times every 2.5 hours), dexamethasone (3.8 mg, 4 times every 2.5 hours), antihistamine (10 mg, 2 times every 5 hours)
Trial: 3361170
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antiemetic agents)
Trial: 3361170
Drug: Combined antiemetic
RxNorm normalized name: ANTIEMETICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined antiemetic agents
Trial: 21984028
Drug: Clonidine 1
RxNorm normalized name: apraclonidine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 1 μg/kg IV
Trial: 2127016
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) as add-on therapy
Trial: 2085059
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg vitamin E (d‐alpha‐tocopherolacetate, V, n = 26)
Trial: 2085059
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg Diclofenac (D, n = 27)
Trial: 2085059
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg vitamin E (V)
Trial: 2085059
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg Diclofenac (D)